Australian medtech business Global Kinetics Corp. developed an FDA-approved device that evaluates and scores users for bradykinesia — a slowness of movement associated with Parkinson’s disease, dyskinesia — involuntary muscle movements, and tremor.

Read more on MedCity News here.